Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment

Leukemia. 2014 Sep;28(9):1912-4. doi: 10.1038/leu.2014.138. Epub 2014 Apr 15.

Authors

R Fu¹, M Xuan¹, Y Zhou¹, T Sun¹, J Bai¹, Z Cao¹, L Zhang¹, H Li¹, D Zhang¹, X Zhang¹, C Lv¹, F Xue¹, X Liu¹, R Yang¹, L Zhang¹

Affiliation

¹ Thrombosis and Hemostasis Center, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

PMID: 24732593
DOI: 10.1038/leu.2014.138

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Calreticulin / genetics*
Humans
Mutation*
Prognosis
Thrombocythemia, Essential / diagnosis
Thrombocythemia, Essential / genetics*
Thrombocythemia, Essential / therapy

Substances

Calreticulin